Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1358 Tissue-targeted lipid nanoparticle delivery for mRNA encoding bispecific T-cell engager demonstrated potent antitumor effects on both hematological malignancies and solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.